Codetta Biosciences
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800 Perimeter Park Dr, Morrisville, Nor...Website
www.codettabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Codetta Biosciences
Codetta Bio specializes in multi-omics technology for precision medicine, offering a platform that integrates the analysis of proteins, DNA, and RNA in a single workflow. Their flagship product, the Codetta Bio Concerto System, utilizes advanced techniques such as digital PCR and qPCR to deliver high-sensitivity and high-throughput biomarker measurements. The company targets various sectors including vaccine development, oncology, and gene therapy, aiming to redefine capabilities in translational research and clinical markets. With a focus on innovation and precision, Codetta Bio seeks to harmonize scientific data to facilitate breakthroughs in healthcare.Explore more
Codetta Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Codetta Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Codetta Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Codetta Biosciences has new funding data
Codetta Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Codetta Biosciences launches new products
Earning: See what the market has to say on Codetta Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Codetta Biosciences
Check if Codetta Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Codetta Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Codetta Biosciences
Compare insights from companies similar to Codetta Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Codetta Biosciences
<$5M
11-50
Private
$15M
2021
WH
William HenleyScientific Co-founder and Vice President of Research and Innovation
Company Profile Activity
Activity Insights
Codetta Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Codetta Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Codetta Biosciences.
Codetta Biosciences financials insights
Gather financial insights about Codetta Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$15M
Codetta Biosciences Tech Stack
A closer look at the technologies used by Codetta Biosciences
Most Recent Scoops
Lateral Move
Executive Move
New Hire
Executive Move
New Hire
Executive Move
Funding
New Hire
Executive Move
Executive Moves, New Hire
Codetta Biosciences News & Media
Codetta Bio™ Expands Global Commercial Leadership to Accelerate Worldwide Adoption of the Concerto™ System
DURHAM, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Codetta Bio™, a leading innovator in multi-omic solutions that integrate ultrasensitive protein quantitation with simultaneous analysis of nucleic acids (RNA and DNA), today announced a significant expansion of its global commercial organization. This strategic move strengthens the company’s ability to meet growing demand for its Concerto™ system as Codetta transitions from its Technology Access Program (TAP) to full commercial launch.Codetta Bio Launches Concerto™ System at AACR 2025 and Invites Attendees to Be a Part of “The Opening Concerto”
Codetta Bio debuts its Concerto™ System at AACR 2025—an all-in-one multi-omics platform with early access for 50 pioneering researchers.Codetta Bio to Launch Concerto™ System at AACR 2025 with Exhibitor Spotlight Presentation
Codetta Bio debuts its Concerto™ System at AACR 2025, enabling simultaneous protein, DNA & RNA quantification from one sample. Visit booth 2445.Codetta Bio Welcomes Paul McEwan and Mitch Levine as Independent Board Members
MORRISVILLE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in integrated multi-omics solutions, is proud to announce the addition of two distinguished professionals, Paul McEwan and Mitch Levine, as independent members to the Board of Directors. These seasoned experts bring decades of experience in life sciences, investment strategy, and corporate growth, further strengthening Codetta Bio’s leadership as it continues to innovate in the multi-omics space.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Codetta Biosciences
Sign Up For FreeTo access detailed company insights
Codetta Bio specializes in multi-omics technology for precision medicine, offering a platform that integrates the analysis of proteins, DNA, and RNA in a single workflow. Their flagship product, the Codetta Bio Concerto System, utilizes advanced techniques such as digital PCR and qPCR to deliver high-sensitivity and high-throughput biomarker measur... Read More
